Biomarker based ADHD monitoring
ADHD is a chronic disorder that affects over 128 million children and often continues into adulthood. ADHD includes a combination of persistent problems: difficulty in sustaining attention, hyperactivity and impulsivity as well as behavioral issues.
While treatment won't cure ADHD, it can help a great deal with these symptoms. Treatment typically involves medication and behavioral intervention. Proper diagnosis and ongoing monitoring can make an enormous difference in the patient's quality of life.
THE "TRIAL & ERROR" PROBLEM
ADHD requires continuous monitoring as treatment effectiveness changes over time.
Current monitoring processes are mostly based on subjective, manual questionnaires, provided by educators and parents. This leads to an inefficient “trial and error” approach, resulting in poor treatment monitoring and enormous costs.
At this time, there is no available mechanism that continuously provides an objective view on the success of the child’s chosen treatment and a monitoring of his/her condition over time.
OUR SOLUTION- PASSIVE MONITORING
A clinically validated monitoring software, providing support to caregivers and families in ADHD management & treatment decisions support.
We utilize a machine and deep learning-based engine which analyzes changes in physiological markers (smart wearable agnostic) to provide objective monitoring to physicians and other stakeholders.
Contact us to hear more about our work
WHO ARE WE?
Iluria was founded in 2018 by experienced professionals in the fields of bioinformatics, medical devices and ADHD.
Co. Founder & CEO
Former C-level executive in various Hi-Tech companies with over 23 years of business & managerial experience; Deep acquaintance with the ADHD field
A business and venture capital professional with extensive experience in early-stage startups.
Prof. Liran Carmel
Expert in computational biology, bioinformatics & genetics, Department of Genetics, The Hebrew University of Jerusalem
Machine learning & Python expert. A seasoned technological veteran which served as VP R&D and CEO of various Hi-Tech companies
Prof. Itai Berger
Formerly head of the pediatric neurology unit and neuro cognitive center at Hadassah Medical Center, Jerusalem
Birkat Klimshtein Levy
Owner at Hoshen-PM. +20 years' experience in project and financial management.